Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Antibiot Khimioter ; 52(7-8): 10-6, 2007.
Artigo em Russo | MEDLINE | ID: mdl-18986019

RESUMO

A significant increase of resistance in out-of-hospital and hospital pathogens to antimicrobials is being lately observed all over the world, including the Russian Federation. Within 2005-2007 clinical strains of potential producers of extended spectrum beta-lactamases were isolated in diverse medical centres. The isolates suspected to produce extended spectrum beta-lactamases by the criteria of CLSI (Clinical and Laboratory Standards Institute, USA) were included into the test with the polymerase chain reaction and sequence for detecting the genes of beta-lactamases TEM, SHV, CTX, OXA and MBL by the original primers. The total of 99 isolates of gramnegative bacteria suspected to produce extended spectrum beta-lactamases by the findings of the local laboratories were tested at the National Research Centre of Antibiotics: 44 strains of the family Enterobacteriaceae, 38 strains of P. aeruginosa and 17 strains of A. baumanii. The Enterobacteriaceae isolates were mainly multiple resistant (29.5%) carrying simultaneously the genes of 4 groups of beta-lactamases (TEM, SHV, CTX and OXA). The investigation revealed 1 strain of E. coli having the gene of metal-beta-lactamase VIM. The strains of A. baumanii mainly contained the genes of beta-lactamases OXA (23%). Group CTX-M1 prevailed (95%) among the detected genes CTX, 2 strains of group CTX-M9 were also isolated. The mechanisms of antibiotic resistance were not elucidated in 35 strains of P. aeruginosa (92%), gene TEM being detected only in 1 strain and gene MBL (metal-beta-lactamase) being detected in 2 strains. The prevalence of multiple resistant strains carrying the beta-lactamase genes OXA and TEM in the medical centres was shown. The most negative fact was isolation of the E. coli strain producing metal-beta-lactamase.


Assuntos
Antibacterianos/uso terapêutico , Infecções Bacterianas/microbiologia , Proteínas de Bactérias/metabolismo , Infecção Hospitalar/microbiologia , Bactérias Gram-Negativas/efeitos dos fármacos , Resistência beta-Lactâmica , beta-Lactamases/metabolismo , Infecções Bacterianas/tratamento farmacológico , Proteínas de Bactérias/genética , Infecção Hospitalar/tratamento farmacológico , Enterobacteriaceae/efeitos dos fármacos , Enterobacteriaceae/enzimologia , Escherichia coli/efeitos dos fármacos , Escherichia coli/enzimologia , Bactérias Gram-Negativas/enzimologia , Humanos , Testes de Sensibilidade Microbiana , Moscou , Pseudomonas aeruginosa/efeitos dos fármacos , Pseudomonas aeruginosa/enzimologia , Federação Russa , beta-Lactamases/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...